Literature DB >> 19610069

Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study.

Aliki J Taylor1, Adam P Croft, Aimee M Palace, David L Winter, Raoul C Reulen, Charles A Stiller, Michael C G Stevens, Mike M Hawkins.   

Abstract

Second primary neoplasms (SPNs) are a recognised late effect of treatment for childhood cancer. Thyroid SPNs can develop after exposure to low-dose radiation, due to the radio-sensitivity of the thyroid gland. The British Childhood Cancer Survivor Study (BCCSS) was set up to directly monitor the late effects of treatment, including risk of SPNs, in childhood cancer survivors and includes 17,980 5-year survivors. We carried out a cohort analysis to determine the risk of thyroid SPNs in the BCCSS, and estimated risk using standardised incidence ratios (SIRs), relative risk (RR) using multivariate Poisson regression and cumulative incidence curves. There were 340,202 person years at risk subsequent to a 5-year survival, median follow-up 17.4 years per survivor. We identified 50 thyroid SPNs including 31 (62%) papillary carcinomas, 15 (30%) follicular carcinomas and 4 (8%) other types. 88% of thyroid SPNs developed after exposure to radiotherapy in or around the thyroid gland. SIR overall was 18.0 (95% confidence interval 13.4-23.8). Risk of thyroid cancer was highest after Hodgkin's disease: RR 3.3 (1.1-10.1) and Non Hodgkin's Lymphoma: RR 3.4 (1.1-10.7) relative to leukaemia (RR 1.0) (p < 0.001). Survivors treated with radiotherapy in childhood had a RR of 4.6 (1.4-15.1) relative to survivors not treated with radiotherapy (RR 1.0), p = 0003. In conclusion, the risk of thyroid cancer in childhood cancer survivors is relatively high in this cohort of childhood cancer survivors. These results will be of use in counselling survivors of childhood cancer exposed to radiation in or around the thyroid area.

Entities:  

Mesh:

Year:  2009        PMID: 19610069     DOI: 10.1002/ijc.24581

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

1.  Thirty-Five Years of Thyroid Cancer Experience in a Paediatric Population: Incidence Trends in Lithuania between 1980 and 2014.

Authors:  Rima Bėrontienė; Edita Jašinskienė; Rosita Kiudelienė; Gintaras Kuprionis; Jurgita Makštienė; Raminta Macaitytė; Dalia Marčiulionytė; Lina Poškienė; Agnė Šemetaitė; Vygantas Šidlauskas; Raimondas Valickas; Rimantas Žalinkevičius; Rasa Verkauskienė
Journal:  Eur Thyroid J       Date:  2016-11-09

2.  Cohort Profile: the French childhood cancer survivor study for leukaemia (LEA Cohort).

Authors:  Julie Berbis; Gérard Michel; André Baruchel; Yves Bertrand; Pascal Chastagner; François Demeocq; Justyna Kanold; Guy Leverger; Dominique Plantaz; Marilyne Poirée; Jean-Louis Stephan; Pascal Auquier; Audrey Contet; Jean-Hugues Dalle; Stéphane Ducassou; Virginie Gandemer; Patrick Lutz; Nicolas Sirvent; Marie-Dominique Tabone; Sandrine Thouvenin-Doulet
Journal:  Int J Epidemiol       Date:  2014-03-17       Impact factor: 7.196

Review 3.  Solid tumor second primary neoplasms: who is at risk, what can we do?

Authors:  Kevin C Oeffinger; Shrujal S Baxi; Danielle Novetsky Friedman; Chaya S Moskowitz
Journal:  Semin Oncol       Date:  2013-12       Impact factor: 4.929

4.  Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study.

Authors:  Parveen Bhatti; Lene H S Veiga; Cécile M Ronckers; Alice J Sigurdson; Marilyn Stovall; Susan A Smith; Rita Weathers; Wendy Leisenring; Ann C Mertens; Sue Hammond; Debra L Friedman; Joseph P Neglia; Anna T Meadows; Sarah S Donaldson; Charles A Sklar; Leslie L Robison; Peter D Inskip
Journal:  Radiat Res       Date:  2010-10-06       Impact factor: 2.841

5.  Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer.

Authors:  Stephanie A Kovalchik; Cécile M Ronckers; Lene H S Veiga; Alice J Sigurdson; Peter D Inskip; Florent de Vathaire; Charles A Sklar; Sarah S Donaldson; Harald Anderson; Parveen Bhatti; Sue Hammond; Wendy M Leisenring; Ann C Mertens; Susan A Smith; Marilyn Stovall; Margaret A Tucker; Rita E Weathers; Leslie L Robison; Ruth M Pfeiffer
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

6.  Late thyroid complications in survivors of childhood acute leukemia. An L.E.A. study.

Authors:  Claire Oudin; Pascal Auquier; Yves Bertrand; Philippe Chastagner; Justyna Kanold; Maryline Poirée; Sandrine Thouvenin; Stephane Ducassou; Dominique Plantaz; Marie-Dominique Tabone; Jean-Hugues Dalle; Virginie Gandemer; Patrick Lutz; Anne Sirvent; Virginie Villes; Vincent Barlogis; André Baruchel; Guy Leverger; Julie Berbis; Gérard Michel
Journal:  Haematologica       Date:  2016-03-11       Impact factor: 9.941

7.  Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study.

Authors:  Geeta Lal; Megan Groff; James R Howe; Ronald J Weigel; Sonia L Sugg; Charles F Lynch
Journal:  Ann Surg Oncol       Date:  2012-01-07       Impact factor: 5.344

8.  Late morbidity and mortality in patients with Hodgkin's lymphoma treated during adulthood.

Authors:  Matthew J Matasar; Jennifer S Ford; Elyn R Riedel; Talya Salz; Kevin C Oeffinger; David J Straus
Journal:  J Natl Cancer Inst       Date:  2015-02-24       Impact factor: 13.506

Review 9.  Late endocrine effects of childhood cancer.

Authors:  Susan R Rose; Vincent E Horne; Jonathan Howell; Sarah A Lawson; Meilan M Rutter; Gylynthia E Trotman; Sarah D Corathers
Journal:  Nat Rev Endocrinol       Date:  2016-04-01       Impact factor: 43.330

10.  Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015.

Authors:  Sara J Schonfeld; Lindsay M Morton; Amy Berrington de González; Rochelle E Curtis; Cari M Kitahara
Journal:  Cancer Epidemiol       Date:  2019-12-26       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.